Covered recipient · General Payments record
NEIL S SADICK
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$716,809.31
- Reported across 362 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $10,918.75 | 4 |
| Food and Beverage | $3,798.46 | 32 |
| Education | $16.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $7,553.36 | 17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,805.00 | 2 |
| Lumenis BE inc | $2,337.31 | 1 |
| LEO Pharma Inc. | $181.78 | 2 |
| Amgen Inc. | $168.51 | 3 |
| Janssen Biotech, Inc. | $160.92 | 2 |
| Bausch Health US, LLC | $121.36 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $110.00 | 1 |
| Lilly USA, LLC | $53.09 | 2 |
| Incyte Corporation | $49.76 | 1 |
| E.R. Squibb & Sons, L.L.C. | $49.52 | 2 |
| Biofrontera Inc. | $39.62 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.73 | 1 |
| Regeneron Healthcare Solutions, Inc. | $36.39 | 1 |
| Galderma Laboratories, L.P. | $30.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2,081.25 | 01/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105997333 | CMS |
| ABBVIE INC. | $14.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997335 | CMS |
| ABBVIE INC. | $8.45 | 02/19/2024 | Education | Undisputed | 01/23/2026 | 1105997337 | CMS |
| ABBVIE INC. | $8.45 | 02/19/2024 | Education | Undisputed | 01/23/2026 | 1105997339 | CMS |
| ABBVIE INC. | $23.00 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997341 | CMS |
| ABBVIE INC. | $29.52 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997343 | CMS |
| ABBVIE INC. | $9.76 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997345 | CMS |
| ABBVIE INC. | $12.08 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997347 | CMS |
| ABBVIE INC. | $61.50 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997349 | CMS |
| ABBVIE INC. | $11.67 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997351 | CMS |
| ABBVIE INC. | $159.93 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997353 | CMS |
| ABBVIE INC. | $15.17 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997355 | CMS |
| ABBVIE INC. | $13.50 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997357 | CMS |
| ABBVIE INC. | $1,387.50 | 08/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105997359 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997361 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997363 | CMS |
| ABBVIE INC. | $3,700.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105997365 | CMS |
| Amgen Inc. | $116.84 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117672655 | CMS |
| Amgen Inc. | $24.65 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117672651 | CMS |
| Amgen Inc. | $27.02 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117672653 | CMS |
| Bausch Health US, LLC | $121.36 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148022750 | CMS |
| Biofrontera Inc. | $39.62 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092759359 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101511466 | CMS |
| E.R. Squibb & Sons, L.L.C. | $30.00 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101511557 | CMS |
| Galderma Laboratories, L.P. | $30.76 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145325633 | CMS |
| Incyte Corporation | $49.76 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141258731 | CMS |
| Janssen Biotech, Inc. | $150.00 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078458340 | CMS |
| Janssen Biotech, Inc. | $10.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078450317 | CMS |
| LEO Pharma Inc. | $131.78 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152649415 | CMS |
| LEO Pharma Inc. | $50.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152649417 | CMS |
| Lilly USA, LLC | $25.41 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135294657 | CMS |
| Lilly USA, LLC | $27.68 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135246234 | CMS |
| Lumenis BE inc | $2,337.31 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082155328 | CMS |
| Novartis Pharmaceuticals Corporation | $110.00 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087306117 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.39 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114151992 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.73 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152187355 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137666434 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,750.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1137666436 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.